HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Serial changes of lung morphology and biochemical profiles in a rat model of bronchopulmonary dysplasia induced by intra-amniotic lipopolysaccharide and postnatal hyperoxia.

AbstractAIM:
to investigate serial changes of lung morphology and biochemical profiles in a rat model of bronchopulmonary dysplasia (BPD) induced by intra-amniotic lipopolysaccharide (LPS) administration and postnatal hyperoxia (85%).
METHODS:
we evaluated histological changes of the lungs and compared the levels of interleukin-6 (IL-6), vascular endothelial growth factor (VEGF), and protein carbonyl in lung tissue on days 1, 7, and 14 after birth in a rat model of BPD.
RESULTS:
the inhibition of alveolarization was sustained in the LPS plus hyperoxia group from day 7 to 14, whereas alveolarization resumed in the hyperoxia group after oxygen exposure was withdrawn at day 7. Administration of LPS alone did not adversely affect lung morphometry. IL-6 levels showed transient overexpression at day 1 in the LPS-treated groups, but decreased at days 7 and 14. VEGF protein levels were elevated in the LPS-treated groups, but not in the hyper-oxia and control groups at days 1, 7, and 14. Exposure to hyperoxia affected protein carbonyl levels in the hyperoxia group at days 7 and 14.
CONCLUSION:
lung injury induced by intra-amniotic inflammation and postnatal hyperoxia may be due to inhibition of alveolarization without recovery even after withdrawal of oxygen.
AuthorsHyun Ju Lee, Chang Won Choi, Beyong Il Kim, Ee-Kyung Kim, Han-Suk Kim, Jung-Hwan Choi, Myong Jin Lee, Eun Gyeong Yang
JournalJournal of perinatal medicine (J Perinat Med) Vol. 38 Issue 6 Pg. 675-81 (11 2010) ISSN: 1619-3997 [Electronic] Germany
PMID20707615 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Interleukin-6
  • Lipopolysaccharides
  • VEGFA protein, human
  • Vascular Endothelial Growth Factor A
Topics
  • Animals
  • Animals, Newborn
  • Bronchopulmonary Dysplasia (chemically induced, metabolism, pathology)
  • Disease Models, Animal
  • Female
  • Histocytochemistry
  • Humans
  • Hyperoxia (pathology)
  • Infant, Newborn
  • Interleukin-6 (metabolism)
  • Lipopolysaccharides (pharmacology)
  • Male
  • Pregnancy
  • Protein Carbonylation
  • Pulmonary Alveoli (drug effects, metabolism, ultrastructure)
  • Rats
  • Rats, Sprague-Dawley
  • Survival Analysis
  • Vascular Endothelial Growth Factor A (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: